Definitive Contract 140D0426C0003
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a $114,994.06 firm fixed price purchase order to the University of Massachusetts to conduct research on the human gut microbiome and its relation to foodborne illness. This is a follow-on to a previous award (HHSF223201710435P) and does not have a set-aside designation. The research will include in-depth literature reviews on the impact of probiotic foods/supplements and microbiome-altering ingredients on the gut...
- This is a firm fixed price delivery order contract award to Ezbiome Inc., a self-certified small disadvantaged business, by the U.S. Army Medical Command (MEDCOM) for microbiome sequencing and analysis services. The contract has a ceiling value of $58,240.00 and will run through June 14, 2025. Ezbiome Inc. previously provided similar metagenomic bioinformatics, next-generation sequencing, and microbiome analysis services to other federal agencies such as the Department of Agriculture and...
- This is a firm-fixed-price purchase order award to Diversigen, Inc., a microbiome analysis and sequencing company, by the Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Metabolic Epidemiology Branch (MEB). The $134,284.00 contract is to evaluate methods for ascertaining microbial communities in oral and fecal samples to support NCI's cancer research. The work includes DNA...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to Corebiome, Inc.'s Diversigen Division, a small business. The contract, valued at $107,689.00, is for whole genome shallow shotgun sequencing on 683 human fecal samples from the Baltimore Longitudinal Study of Aging (BLSA) to examine microbiome changes with age and their relation to age-related conditions like cognitive impairment. Corebiome,...
- The National Institutes of Health National Human Genome Research Institute awarded Metabolon, Inc. a $53,420 fixed-price purchase order to conduct fecal metabolomic profiling of individuals of African descent with metabolic disorders. The work will be performed in Morrisville, North Carolina over a one-year period ending August 2024. Through this contract, Metabolon will analyze stool samples to develop metabolic profiles for research participants, as requested in the original solicitation...
- The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), awarded a sole-source contract to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic analysis services. The $28,991.20 firm-fixed-price purchase order is to support the Liver Diseases Branch's research on microbiomes and their effects on host physiology and immune responses. Metabolon will use ultra-high performance liquid chromatography...
- This is a $547,646 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Microbiome Health Research Institute Inc. (doing business as Openbiome), a non-profit organization. The contract is for the R.A.C.E. program, which involves the recruitment and enrollment of 180 patients, treatment of 20 patients including sample collection and follow up for a clinical trial. Microbiome Health Research Institute Inc. has subcontracted a portion of the work...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), awarded a $180,000.00 firm-fixed-price purchase order contract to Exonova Biosciences LLC, a woman-owned small business, for the services of a Contract Inflammatory and Vascular Diseases Scientist. The contract, which has no set-aside designation, requires a PhD-level scientist with over 15 years of specialized experience in immunology or inflammation research to support...
- This federal contract award was made by the U.S. Environmental Protection Agency (EPA) to Microbiome Engineering, LLC, a woman-owned small business located in Albany, California. The contract, valued at $99,994.16, is for an SBIR (Small Business Innovation Research) Phase I project under the EPA's Office of Research and Development. The contract has a firm fixed-price pricing type and a final completion date of October 31, 2019. As this is a Small Business set-aside contract, Microbiome...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $190,000 firm fixed-price purchase order to Exonova Biosciences LLC on January 1, 2026, for scientific support services focused on inflammatory and vascular diseases. The contract, which extends through December 31, 2026, supports the Biomedical and Metabolic Imaging Branch and was awarded without full and open competition under simplified acquisition procedures. The procurement was designated as a Total Small...
The National Institutes of Health awarded a $597,482 firm fixed-price contract to Evimero, LLC, a small business, for a feasibility study titled "Leveraging the Gut Microbiome as an Integrator of Nutritional Status: A Feasibility Study of Microbiome Nutritional Diagnostics (MINU-DX)." The work will be performed in Tuscaloosa, Alabama, with an ultimate completion date of March 9, 2028. This total small business set-aside contract represents the NIH's investment in exploring innovative diagnostic approaches that integrate microbiome analysis with nutritional assessment methodologies. The MINU-DX project aligns with the NIH's broader research priorities in understanding the human microbiome and its relationship to health outcomes, nutritional status, and disease prevention. By conducting a feasibility study on microbiome-based nutritional diagnostics, Evimero will help establish the scientific and technical foundation for developing diagnostic tools that could leverage gut microbiome composition as a biomarker for assessing an individual's nutritional health. This work contributes to advancing personalized medicine and nutrition science through the integration of microbiome research with clinical diagnostics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $597.5k | 3/3/26 |